PI
TXMD icon

Putnam Investments’s TherapeuticsMD TXMD Stock Holding History

Putnam Investments’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-903
Closed -$325K – 1291
2017
Q1 		$325K Sell
903
-1,337
-60% -$414K ﹤0.01% 1163
2016
Q4 		$646K Sell
2,240
-78
-3% -$24.2K ﹤0.01% 1091
2016
Q3 		$789K Buy
+2,318
New +$847K ﹤0.01% 1061

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Putnam Investments's TXMD Position: Q2 2017 in Review

Putnam Investments sold out of TherapeuticsMD (TXMD) in Q2 2017, closing a stake of 903 shares — an estimated $325K sold.

Putnam Investments first reported a position in TXMD in Q3 2016 and held it in 3 quarters. The position peaked at $789K in Q3 2016. 117 funds tracked by Wall St. Rank hold TXMD as of Q2 2017.

  • Putnam Investments reported no remaining TherapeuticsMD position as of Q2 2017 after selling out during the quarter.
  • Putnam Investments sold 903 TherapeuticsMD shares in Q2 2017, an estimated $325K.
  • Putnam Investments first reported a position in TherapeuticsMD in Q3 2016 and held it in 3 quarters.
  • Putnam Investments's TherapeuticsMD position peaked at $789K in Q3 2016.
  • 117 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2017.

Based on Putnam Investments's 13F filing for Q2 2017, filed 14 Aug 2017.